Select Medical Holdings CORP Form 4 insider transactions

NYSE
A director at Select Medical Holdings Corporation, Marilyn B Tavenner, sold 32,000 shares of common stock at an average price of $21.09.
NYSE
Thomas P. Mullin, Co-President of Select Medical Holdings Corp, disposed of shares to cover tax obligations related to vesting restricted stock.
NYSE
Brian R. Rusignuolo, Chief Information Officer of Select Medical Holdings Corp, reports the surrender of shares to cover tax obligations related to vesting restricted stock on November 5, 2024.
NYSE
Michael Malatesta, CFO of Select Medical Holdings, disposed of shares to cover tax obligations related to the vesting of restricted stock.
NYSE
Executive Vice President of Select Medical Holdings, Jackson Martin F, disposed of shares to cover tax obligations related to vesting restricted stock.
NYSE
David Chernow, President and CEO of Select Medical Holdings, disposed of shares to cover tax obligations related to vesting restricted stock.
NYSE
John A. Saich, Executive Vice President of Select Medical Holdings, disposed of shares to cover tax obligations related to vesting restricted stock.
NYSE
Executive Vice President Michael Tarvin of Select Medical Holdings Corp. reports surrendering shares to cover tax obligations related to vesting restricted stock.
NYSE
Christopher Weigl, Chief Accounting Officer of Select Medical Holdings Corp, reports the surrender of shares to cover tax obligations related to vesting restricted stock on November 5, 2024.
NYSE
Robert G. Breighner JR, Vice President of Compliance at Select Medical Holdings Corp, disposed of shares to cover tax obligations related to vesting restricted stock.
NYSE
Director Parvinderjit S. Khanuja acquired 543 shares of Select Medical Holdings Corp common stock at $33.14 per share in lieu of a pro-rated quarterly retainer.
NYSE
Director William H. Frist acquired 543 shares of Select Medical Holdings Corp. common stock on October 29, 2024, in lieu of a pro-rated quarterly retainer.
NYSE
Co-President Mullin Thomas P surrendered 11,023 shares of Select Medical Holdings Corp to cover tax obligations related to vesting restricted stock on October 27, 2024.
NYSE
Brian R. Rusignuolo, Chief Information Officer of Select Medical Holdings Corp, reported disposing of 11,010 shares of common stock to cover tax obligations related to vesting restricted stock.
NYSE
Michael Malatesta, CFO of Select Medical Holdings, reports the surrender of shares to cover tax obligations related to vesting restricted stock on October 27, 2024.
NYSE
Rocco A. Ortenzio, Chairman Emeritus and Co-Founder of Select Medical Holdings Corp, reports a transfer of 220,000 shares of common stock to the Rocco A. Ortenzio Revocable Trust.
NYSE
Brian R. Rusignuolo, Chief Information Officer of Select Medical Holdings Corp, reports the surrender of shares to cover tax obligations related to vesting restricted stock.
NYSE
John A. Saich, Executive Vice President of Select Medical Holdings, disposed of shares to cover tax obligations related to vesting restricted stock.
NYSE
Thomas P. Mullin, Co-President of Select Medical Holdings Corp, sold shares to cover tax obligations related to vesting restricted stock.
NYSE
Michael E. Tarvin, Executive Vice President of Select Medical Holdings, disposed of shares to cover tax obligations related to vesting restricted stock.
NYSE
Robert Ortenzio, Executive Chairman of Select Medical Holdings, filed a Form 4 disclosing changes in beneficial ownership of company stock due to tax withholding obligations and indirect ownership through trusts.
NYSE
Executive Vice President Jackson Martin F. of Select Medical Holdings Corp. reports a transaction involving the surrender of shares to cover tax obligations.
NYSE
David Chernow, CEO of Select Medical Holdings, disposed of shares to cover tax obligations related to vesting restricted stock.
NYSE
Martin F. Jackson, Executive Vice President of Select Medical Holdings, reports the surrender of shares to cover tax obligations related to vesting restricted stock.
NYSE
Executive Vice President Michael Tarvin of Select Medical Holdings Corp. reports the surrender of shares to cover tax obligations related to vesting restricted stock.
NYSE
David Chernow, President and CEO of Select Medical Holdings, disposed of shares to cover tax obligations related to vesting restricted stock.
NYSE
Director Parvinderjit S. Khanuja acquired 453 shares of Select Medical Holdings Corp common stock at $39.76 per share in lieu of a quarterly retainer.
NYSE
Director William H. Frist acquired 453 shares of Select Medical Holdings Corp. common stock on July 30, 2024, in lieu of a pro-rated quarterly retainer.
NYSE
Rocco A. Ortenzio, Vice Chairman & Co-Founder of Select Medical Holdings Corp, reports transferring 200,000 shares of common stock to the Rocco A. Ortenzio Revocable Trust.
NYSE
Brian R. Rusignuolo, Chief Information Officer of Select Medical Holdings Corp, was granted 75,000 shares of restricted stock on April 30, 2024, which will vest in full on April 30, 2027.